about
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer typesAlcohol intake and risk of non-Hodgkin lymphoma in men and womenGenome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphomaGenetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypesMedical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectEtiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectGenome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroupsA genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemiaGenome-wide association study identifies multiple risk loci for chronic lymphocytic leukemiaA genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in SwedenPatterns of acute inflammatory symptoms prior to cancer diagnosis.GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphomaGenome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes ProjectBirth order and risk of non-hodgkin lymphoma--true association or bias?Borrelia infection and risk of non-Hodgkin lymphomaGenome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.A meta-analysis of genome-wide association studies of follicular lymphomaMalignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics.A genome-wide association study of marginal zone lymphoma shows association to the HLA region.Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphomaHigh prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers.Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerationsLPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival.Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium.The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies.Autoimmune and Atopic Disorders and Risk of Classical Hodgkin LymphomaSelf-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph ConsortiumWhole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutationsMeta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.
P50
Q24170413-83C6DEEA-6EA2-48E9-917E-25CD3C49141FQ28242742-9C4E2EAC-21A5-4DFA-B99C-762746A3C1A4Q28248768-4C66BF44-FA31-496E-BA2E-F4F54FBF3905Q28393571-2D5A958B-7E0F-4578-9BCA-8968D9854D3DQ28393760-64663663-850E-4289-9096-B9E8FB9DEE57Q28393769-0A3BE8D3-FD5D-475B-8A1F-169F617A6E07Q28943266-E5578392-8F50-4D82-BA97-D0D84899115CQ28943318-1DB554BA-1D85-460A-9778-77D49F5991D1Q28943339-65C77309-4646-4579-A912-8EA978EA14EAQ28943455-F328E6F0-99DB-4D63-A7F2-C5474BB3F437Q30828481-88FD173C-BC88-4960-8529-C1170FF0F80FQ33669405-CCA8A956-30CB-4077-8245-25BF20428B32Q33886166-00200877-299C-444B-8E74-CBB1B22AC270Q34033939-98225915-0ADD-4CB8-A544-FDCE44010A5EQ34137915-5659D05B-DA5F-41EB-A453-0C939C1505E4Q34179580-3FEA406E-F7B2-4FB4-9DCF-4E53701B5A16Q34275054-F1E5CF2C-72A8-42C8-9E5B-23AD4D8F3341Q34288685-2B0D1B60-ABFE-4546-B3B3-B9F3DBC0E43EQ34371084-B81A9B6C-458A-4928-B043-78470CEF23DBQ34396112-C4CB3951-F752-4AA8-A14E-7880FCE287A8Q34425597-0E5111D2-456B-4879-A2C0-FE95532F104FQ34583460-B9A0728E-1777-481D-B95B-1A64AF06A8EAQ34672857-A8F1A1CA-EC54-4F0C-B93C-3228EE24D86AQ34881099-DEA8F1DC-A975-4824-BDD5-EAB42C6CB37BQ34999235-24F62914-6296-4F3A-BCEC-002CFB2D401DQ35028835-061B3B4D-7094-4181-B9D9-A1449466813CQ35029461-D4BF5283-BE90-422B-8027-296984689AB9Q35143479-912CE32D-8DD2-4699-863B-76CC18BCED2EQ35143490-9454EB3F-D688-457B-8B9E-5338BDDF9BAAQ35311162-2AFE3F2C-8D00-4319-B81D-A06D93C9A166Q35671227-661D7944-4E85-4228-9D9B-303E62EE64F9Q35815614-8B2AA636-B1CC-422A-91DC-62746F6FA41DQ35832484-655B522A-F204-4768-B00D-F2A703EF8EFBQ36083000-46E62BDD-6E62-4E32-AA54-3EB8F316E857Q36089344-607ACDDE-BF55-432A-A10D-49F8FA2978B5Q36120539-D26C9723-D760-4820-80EF-C429BC2186BDQ36487605-08464FF4-651A-4F71-B540-A5630B7DF02AQ36528740-1B8042AE-AD76-4B7F-B972-15F8252D90A7Q36622188-30902063-8701-4894-B854-D869BBC62F5AQ36675182-AB20B394-8305-4A33-BD86-5102160909D9
P50
name
Karin Ekström Smedby
@ast
Karin Ekström Smedby
@en
Karin Ekström Smedby
@nl
type
label
Karin Ekström Smedby
@ast
Karin Ekström Smedby
@en
Karin Ekström Smedby
@nl
altLabel
Karin E Smedby
@en
Karin E. Smedby
@en
Karin Ekstrom Smedby
@en
prefLabel
Karin Ekström Smedby
@ast
Karin Ekström Smedby
@en
Karin Ekström Smedby
@nl